Has Daavlin Distributing Company had other FDA enforcement actions?

Yes. Argus HQ has recorded 4 total FDA actions tied to Daavlin Distributing Company: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-22; Argus observed and indexed it on 2026-07-28.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Daavlin Distributing Company — Class II recall: Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders

Name: FDA Recall Record — Daavlin Distributing Company
Creator: Argus HQ
Published: 2026-07-22
License: https://argushq.ai/methodology

Event date: 2026-07-22 00:00:00Z
Observed: 2026-07-28 04:20:56Z
Source ID: Z-2742-2026
Payload hash: e82201c3e567ce09e5bdf0ea…

Summary

Calibrated Output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000). Status: Ongoing.

Entities

Daavlin Distributing Company

View source record ↗

Frequently asked questions

Has Daavlin Distributing Company had other FDA enforcement actions?: Yes. Argus HQ has recorded 4 total FDA actions tied to Daavlin Distributing Company: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-22; Argus observed and indexed it on 2026-07-28.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Daavlin Distributing Company — Class II recall: Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-daavlin-distributing-company-z-2742-2026

MLA

"Daavlin Distributing Company — Class II recall: Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-daavlin-distributing-company-z-2742-2026.

Chicago

Argus HQ Research. "Daavlin Distributing Company — Class II recall: Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders." Digital Empire Holdings LLC. Accessed July 28, 2026. https://argushq.ai/events/fda-recall-daavlin-distributing-company-z-2742-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_daavlin_distributing_company_z_2742_2026_2026,
  title = {Daavlin Distributing Company — Class II recall: Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-daavlin-distributing-company-z-2742-2026},
  note = {Accessed: July 28, 2026}
}

Informational only. Not legal, financial, or medical advice.